Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...

The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...

As the U.S. focuses on beefing up its biopharma manufacturing infrastructure this year, a similar effort toward improved drug ...

The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year.

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Daniel McIver spoke about the challenges and rewards of his ...

Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...

Two-thirds of respondents who have faced fertility challenges said their workplaces don’t offer support for employees undergoing fertility treatment. Support is rarest in France, where 88% of ...

The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM), which spurred excitement over a potential $20 billion ...

Lawmakers are proposing a new effort to strengthen biopharma manufacturing in the U.S., leveraging a bill that seeks to ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...

Incyte is strutting its stuff to boost awareness and support for people with vitiligo—with help from supermodel Winnie Harlow ...

Back in August, the FDA announced that it was working on a new program dubbed FDA PreCheck, which broadly aims to improve ...